なぜ私たちはFDAを去ったのか：6人の元職員が語る物語
原題: Why we left the FDA: Six former officials share their stories
分析結果
- カテゴリ
- 医療
- 重要度
- 51
- トレンドスコア
- 12
- 要約
- この記事では、6人の元FDA職員が組織を離れた理由を語っています。彼らは、規制の厳しさや内部の圧力、倫理的なジレンマなど、さまざまな要因が影響したと述べています。FDAの決定が公衆の健康に与える影響や、職場環境の問題についても触れ、改革の必要性を訴えています。
- キーワード
In this week's STATus Report, hear from six former FDA officials on why they left the agency. In this week's STATus Report, hear from six former FDA officials on why they left the agency. A year after U.S. DOGE Service cuts shook up the federal government, STAT’s FDA reporter Lizzy Lawrence has been speaking with former officials about their time at the agency. Two weeks ago, I hit the road with Lizzy to interview six of them about what drew them to the agency, the important work they did during their career there, and, ultimately, why they decided to leave during the second Trump administration. In a special road-trip edition of STATus Report, Lizzy and I travel around the leafy suburbs of Washington to bring you first-person testimonies, including the former director of the FDA’s Center for Drug Evaluation and Research, Richard Pazdur; Sheryl Lard-Whiteford, a leader in the FDA’s biologics center; and Julie Tierney, who worked on Operation Warp Speed.